Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Hillmen P, Pitchford A, Bloor A, Broom A, Young M, Kennedy B, Walewska R, Furtado M, Preston G, Neilson JR, Pemberton N, Sidra G, Morley N, Cwynarski K, Schuh A, Forconi F, Elmusharaf N, Paneesha S, Fox CP, Howard DR, Hockaday A, Brown JM, Cairns DA, Jackson S, Greatorex N, Webster N, Shingles J, Dalal S, Patten PEM, Allsup D, Rawstron A, Munir T. Hillmen P, et al. Among authors: pitchford a. Lancet Oncol. 2023 May;24(5):535-552. doi: 10.1016/S1470-2045(23)00144-4. Lancet Oncol. 2023. PMID: 37142374 Free article. Clinical Trial.
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis.
Ravichandran S, Hall A, Jenner M, Garg M, Kishore B, Lachmann H, Gillmore J, Pitchford A, Oughton JB, Mahmood S, Sachchithantham S, Hawkins P, Brown S, Wechalekar A. Ravichandran S, et al. Among authors: pitchford a. Amyloid. 2023 Sep;30(3):290-296. doi: 10.1080/13506129.2023.2169124. Epub 2023 May 22. Amyloid. 2023. PMID: 37216268 Clinical Trial.
Watershed-based survey designs.
Detenbeck NE, Cincotta D, Denver JM, Greenlee SK, Olsen AR, Pitchford AM. Detenbeck NE, et al. Among authors: pitchford am. Environ Monit Assess. 2005 Apr;103(1-3):59-81. doi: 10.1007/s10661-005-4774-7. Environ Monit Assess. 2005. PMID: 15861987 Review.
Treatment for ovarian carcinoma.
Barr W, Edelstyn GA, Forster DM, Glennie JM, Mackae KD, Menzies DN, O'Sullivan JF, Pitchford AG, Smedley GT, Tacchi D, Ward HW. Barr W, et al. Among authors: pitchford ag. Br Med J. 1972 Mar 18;1(5802):749-50. doi: 10.1136/bmj.1.5802.749-c. Br Med J. 1972. PMID: 5015340 Free PMC article. No abstract available.
Treatment of ovarian carcinoma.
Barr W, Edelstyn GA, Forster DM, Glennie JM, MacRae KD, Menzies DN, O'Sullivan J, Pitchford AG, Smedley GT, Tacchi D, Ward HW. Barr W, et al. Among authors: pitchford ag. Lancet. 1972 Mar 11;1(7750):591. doi: 10.1016/s0140-6736(72)90382-0. Lancet. 1972. PMID: 4110070 No abstract available.
11 results